| Product Code: ETC6532450 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Non-alcoholic Steatohepatitis Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Non-alcoholic Steatohepatitis Market - Industry Life Cycle |
3.4 Brunei Non-alcoholic Steatohepatitis Market - Porter's Five Forces |
3.5 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.7 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F |
3.8 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Brunei Non-alcoholic Steatohepatitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about non-alcoholic steatohepatitis (NASH) in Brunei |
4.2.2 Growing prevalence of obesity and diabetes in Brunei, leading to a higher risk of NASH |
4.2.3 Government initiatives to improve healthcare infrastructure and services in Brunei |
4.3 Market Restraints |
4.3.1 Limited availability of specialized treatment options for NASH in Brunei |
4.3.2 High cost associated with NASH diagnosis and treatment in Brunei |
5 Brunei Non-alcoholic Steatohepatitis Market Trends |
6 Brunei Non-alcoholic Steatohepatitis Market, By Types |
6.1 Brunei Non-alcoholic Steatohepatitis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F |
6.1.4 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F |
6.1.5 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F |
6.1.6 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F |
6.1.7 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F |
6.1.8 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Brunei Non-alcoholic Steatohepatitis Market, By Sales Channel |
6.2.1 Overview and Analysis |
6.2.2 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F |
6.2.4 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3 Brunei Non-alcoholic Steatohepatitis Market, By Disease Cause |
6.3.1 Overview and Analysis |
6.3.2 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F |
6.3.3 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F |
6.3.4 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F |
6.3.5 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3.6 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F |
6.4 Brunei Non-alcoholic Steatohepatitis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Brunei Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F |
7 Brunei Non-alcoholic Steatohepatitis Market Import-Export Trade Statistics |
7.1 Brunei Non-alcoholic Steatohepatitis Market Export to Major Countries |
7.2 Brunei Non-alcoholic Steatohepatitis Market Imports from Major Countries |
8 Brunei Non-alcoholic Steatohepatitis Market Key Performance Indicators |
8.1 Average time taken for NASH diagnosis in Brunei |
8.2 Number of healthcare professionals trained in NASH management in Brunei |
8.3 Patient adherence rate to NASH treatment plans in Brunei |
9 Brunei Non-alcoholic Steatohepatitis Market - Opportunity Assessment |
9.1 Brunei Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Brunei Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.3 Brunei Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F |
9.4 Brunei Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Brunei Non-alcoholic Steatohepatitis Market - Competitive Landscape |
10.1 Brunei Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024 |
10.2 Brunei Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here